BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Watts JK, Brown RH, Khvorova A. Nucleic Acid Therapeutics for Neurological Diseases. Neurotherapeutics 2019;16:245-7. [PMID: 31037650 DOI: 10.1007/s13311-019-00736-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Dobrovolskaia MA. Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies. Molecules 2019;24:E4620. [PMID: 31861154 DOI: 10.3390/molecules24244620] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
2 Liu Y, Liu Z, Cui W, Li Y, Qin X, Zhang M, Lin Y. Tetrahedral framework nucleic acids as an advanced drug delivery system for oligonucleotide drugs. APL Materials 2020;8:100701. [DOI: 10.1063/5.0025211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Mendonça MCP, Kont A, Aburto MR, Cryan JF, O'Driscoll CM. Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System. Mol Pharm 2021;18:1491-506. [PMID: 33734715 DOI: 10.1021/acs.molpharmaceut.0c01238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Chavda V, Madhwani K. Coding and non-coding nucleotides': The future of stroke gene therapeutics. Genomics 2021;113:1291-307. [PMID: 33677059 DOI: 10.1016/j.ygeno.2021.03.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Boumil EF, Castro N, Phillips AT, Chatterton JE, McCauley SM, Wolfson AD, Shmushkovich T, Ridilla M, Bernstein AM. USP10 Targeted Self-Deliverable siRNA to Prevent Scarring in the Cornea. Mol Ther Nucleic Acids 2020;21:1029-43. [PMID: 32829179 DOI: 10.1016/j.omtn.2020.07.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 McIntosh CS, Li D, Wilton SD, Aung-Htut MT. Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies. Biomedicines 2021;9:1499. [PMID: 34829728 DOI: 10.3390/biomedicines9111499] [Reference Citation Analysis]
7 Nguyen LD, Chau RK, Krichevsky AM. Small Molecule Drugs Targeting Non-Coding RNAs as Treatments for Alzheimer's Disease and Related Dementias. Genes (Basel) 2021;12:2005. [PMID: 34946953 DOI: 10.3390/genes12122005] [Reference Citation Analysis]